Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-FR Version v2-FR
Language French French
Date Updated 2024-05-07 2024-03-21
Drug Identification Number 01981242 01981242
Brand name DESFERAL 500MG DESFERAL 500MG
Common or Proper name DESFERAL VIALS 500MG 1 X 10 DESFERAL VIALS 500MG 1 X 10
Company Name NOVARTIS PHARMACEUTICALS CANADA INC NOVARTIS PHARMACEUTICALS CANADA INC
Ingredients DEFEROXAMINE MESYLATE DEFEROXAMINE MESYLATE
Strength(s) 500MG 500MG
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration SUBCUTANEOUS INTRAVENOUS INTRAPERITONEAL INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAPERITONEAL INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAPERITONEAL INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAPERITONEAL INTRAMUSCULAR
Packaging size 1 x 10 1 x 10
ATC code V03AC V03AC
ATC description ALL OTHER THERAPEUTIC PRODUCTS ALL OTHER THERAPEUTIC PRODUCTS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2024-03-21 2024-09-04
Actual start date
Estimated end date 2024-06-14 2024-09-04
Actual end date
Shortage status Actual shortage Anticipated shortage
Tier 3 Status No No
Company comments Product is on allocation to minimize patient impact. Product is on allocation to minimize patient impact.
Health Canada comments